4.6 Article

Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases

Journal

ANTIBIOTICS-BASEL
Volume 8, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/antibiotics8020072

Keywords

Chronic Lyme disease; neuroborreliosis; Post-treatment Lyme disease syndrome (PTLDS); relapsing babesiosis; persistent infection; antibiotic treatment failure; disulfiram

Ask authors/readers for more resources

Three patients, each of whom had required intensive open-ended antimicrobial therapy for control of the symptoms of chronic relapsing neurological Lyme disease and relapsing babesiosis, were able to discontinue treatment and remain clinically well for periods of observation of 6-23 months following the completion of a finite course of treatment solely with disulfiram. One patient relapsed at six months and is being re-treated with disulfiram.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available